Abeona Therapeutics (ABEO) Other Working Capital Changes (2011 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Other Working Capital Changes of -$182000.0 for Q1 2026, up 49.72% year-over-year from -$121557.2 in Q1 2025, and down 138.56% quarter-over-quarter from $472000.0 in Q4 2025.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Other Working Capital Changes (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$182000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 49.72% year-over-year to -$182000.0; the TTM figure through Mar 2026 stood at -$396000.0 (up 71.03% YoY), while the FY2025 annual figure was -$576000.0, up 56.2% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$182000.0, down from $472000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $1.2 million in Q1 2024, with the low at -$915000.0 in Q4 2025.
- The 5-year median for Other Working Capital Changes is -$238000.0 (2023), against an average of -$25058.8.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes retreated 28.08% in 2024, then surged 226.2% in 2025.
- Abeona Therapeutics' Other Working Capital Changes stood at -$292000.0 in 2023, then declined by 28.08% to -$374000.0 in 2024, then soared by 226.2% to $472000.0 in 2025, then plunged by 138.56% to -$182000.0 in 2026.
- Business Quant data shows ABEO's Other Working Capital Changes at -$182000.0 in Q1 2026, $472000.0 in Q4 2025, and -$381000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Jun 30, 2026 | 20,000.00 |
| Mar 31, 2026 | 657,000.00 |
| Mar 31, 2026 | 657,000.00 |
| Dec 31, 2025 | -1.64 Mn |
| Dec 31, 2025 | -1.64 Mn |
| Sep 30, 2025 | 119,000.00 |
| Sep 30, 2025 | 119,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | -374,000.00 |
| Dec 31, 2024 | -374,000.00 |
| Sep 30, 2024 | -1.58 Mn |
| Sep 30, 2024 | -1.58 Mn |
| Jun 30, 2024 | -593,000.00 |
| Jun 30, 2024 | -593,000.00 |
| Mar 31, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.23 Mn |